ArticleEndocrinology and metabolism (Seoul, Korea)2021

Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia.

Brian Tomlinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.